Haynes and Boone·FDA / LIFE SCIENCES REGULATORY
FDA issues discussion paper seeking input on GenAI-enabled devices
The FDA's Aug. 19 discussion paper proposes regulatory concepts for generative AI-enabled medical devices and invites industry comment, an early step rather than binding policy.
fdamedical-devicesgenerative-airegulatory-pathwaydiscussion-paperai-enabled-devices
Read the original firm alert → Tuesday, October 6, 2026